Inventor · disambiguated record
Songnian Lin
Also filed as: LIN SONGNIAN
30 granted patents·21 pending applications·48 citations·filing 2005–2024
94Inventor score
Files withMERCK SHARP & DOHME24MERCK SHARP & DOHME LLC12LIN SONGNIAN5FENG DANQING2BIANCHI ELISABETTA1
Top patents by PatentIndex Score
51 records- 0187US10183981B2Insulin receptor partial agonistsMERCK SHARP & DOHME·Filed 2018·Granted Jan 22, 2019·5 cites·6 claims
- 0284US9427475B2Glucose-responsive insulin conjugatesMERCK SHARP & DOHME·Filed 2014·Granted Aug 30, 2016·5 cites·4 claims
- 0384US7442808B2Antidiabetic bicyclic compoundsMERCK & CO INC·Filed 2007·Granted Oct 28, 2008·11 cites·13 claims
- 0482US11413352B2Conjugate based systems for controlled insulin deliveryMERCK SHARP & DOHME LLC·Filed 2018·Granted Aug 16, 2022·2 cites·3 claims
- 0582US10017556B2Insulin receptor partial agonistsMERCK SHARP & DOHME·Filed 2015·Granted Jul 10, 2018·3 cites·10 claims
- 0681US9884125B2Glucose-responsive insulin conjugatesMERCK SHARP & DOHME·Filed 2014·Granted Feb 6, 2018·3 cites·2 claims
- 0780US7759493B2Antidiabetic bicyclic compoundsMERCK SHARP & DOHME·Filed 2006·Granted Jul 20, 2010·9 cites·20 claims
- 0879US11041009B2Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetesMERCK SHARP & DOHME·Filed 2018·Granted Jun 22, 2021·2 cites·6 claims
- 0978US10689430B2Insulin receptor partial agonistsMERCK SHARP & DOHME·Filed 2017·Granted Jun 23, 2020·1 cites·6 claims
- 1076US9527838B22-pyridinecarboxamide derivatives, compositions containing such compounds, and methods of treatmentMERCK SHARP & DOHME·Filed 2013·Granted Dec 27, 2016·1 cites·13 claims
- 1175US8039484B2Antidiabetic bicyclic compoundsMERCK SHARP & DOHME·Filed 2007·Granted Oct 18, 2011·2 cites·14 claims
- 1274US8318667B2Glucagon receptor antagonist compounds, compositions containing such compounds and methods of useLIN SONGNIAN·Filed 2010·Granted Nov 27, 2012·2 cites·20 claims
- 1372US10800827B2Insulin receptor partial agonistsMERCK SHARP & DOHME·Filed 2018·Granted Oct 13, 2020·0 cites·4 claims
- 1472US8399507B2Antidiabetic tricyclic compoundsLIANG GUI-BAI·Filed 2008·Granted Mar 19, 2013·2 cites·4 claims
- 1571US2024101631A1Human interleukin-2 conjugates biased for the interleukin-2 receptor beta-gammac dimer and conjugated to a nonpeptidic, water-soluble polymerMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1665US11827684B2Human interleukin-2 conjugates biased for the interleukin-2 receptor beta GAMMAc dimer and conjugated to a nonpeptidic, water-soluble polymerMERCK SHARP & DOHME LLC·Filed 2021·Granted Nov 28, 2023·0 cites·54 claims
- 1763US2024287138A1Cyclic peptides for inhibiting tnf receptor 1 activityMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1862US2023365646A1Azide insulin analoguesMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1961US9359339B2Glucagon receptor antagonist compounds, compositions containing such compounds and methods of useMERCK SHARP & DOHME·Filed 2014·Granted Jun 7, 2016·0 cites·20 claims
- 2061US2024424109A1Glucose-responsive insulin conjugates comprising a tetra-valent sugar cluster for treatment of diabetesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2157US9889205B2Glucose-responsive insulin conjugatesMERCK SHARP & DOHME·Filed 2016·Granted Feb 13, 2018·0 cites·2 claims
- 2257US2025051416A1Insulin receptor partial agonistsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2357US2023310551A1Insulin receptor partial agonistsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2457US2024294596A1Insulin receptor partial agonistsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2556US11530250B2Tyrosine-specific functionalized insulin and insulin analogsMERCK SHARP & DOHME·Filed 2019·Granted Dec 20, 2022·0 cites·1 claims
- 2656US2023105982A1Insulin-incretin conjugatesMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 2755US9649294B2Glucagon receptor antagonist compounds, compositions containing such compounds and methods of useMERCK SHARP & DOHME·Filed 2014·Granted May 16, 2017·0 cites·9 claims
- 2854US2023270825A1Stapled olefin co-agonists of the glucagon and glp-1 receptorsMERCK SHARP & DOHME LLC·Filed 2020·Application pending·0 cites
- 2954US2023063794A1Stapled triazole co-agonists of the glucagon and glp-1 receptorsMERCK SHARP & DOHME LLC·Filed 2020·Application pending·0 cites
- 3053US11077092B2Methods of treating diabetes by administering a glucagon receptor antagonist in combination with a cholesterol absorption inhibitorMERCK SHARP & DOHME·Filed 2017·Granted Aug 3, 2021·0 cites·15 claims
- 3151US10953076B2Insulin receptor partial agonists and GLP-1 analoguesMERCK SHARP & DOHME·Filed 2017·Granted Mar 23, 2021·0 cites·7 claims
- 3251US2022273770A1Glucose-responsive insulin conjugatesFENG DANQING·Filed 2020·Application pending·0 cites
- 3351US2023285514A1Stapled lactam co-agonists of the glucagon and glp-1 receptorsBIANCHI ELISABETTA·Filed 2020·Application pending·0 cites
- 3449US12427187B2Glucose-responsive insulin conjugatesMERCK SHARP & DOHME LLC·Filed 2020·Granted Sep 30, 2025·0 cites·2 claims
- 3549US8436015B2Glucagon receptor antagonist compounds, compositions containing such compounds and methods of useLIN SONGNIAN·Filed 2009·Granted May 7, 2013·0 cites·17 claims
- 3648US2021163568A1Azide insulin analoguesMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 3747US11820805B2Conjugate based systems for controlled insulin deliveryMERCK SHARP & DOHME·Filed 2018·Granted Nov 21, 2023·0 cites·3 claims
- 3847US8445538B2Glucagon receptor antagonist compoundsLIN SONGNIAN·Filed 2009·Granted May 21, 2013·0 cites·20 claims
- 3946US11058775B2Insulin dimer-incretin conjugatesMERCK SHARP & DOHME·Filed 2017·Granted Jul 13, 2021·0 cites·22 claims
- 4045US2011281795A1Glucagon receptor antagonist compounds, compositions containing such compounds and methods of useLIN SONGNIAN·Filed 2010·Application pending·0 cites
- 4143US9453038B2Glucokinase activator compounds, compositions containing such compounds, and methods of treatmentMERCK SHARP & DOHME·Filed 2013·Granted Sep 27, 2016·0 cites·16 claims
- 4242US2018110863A1Glucose-responsive insulin conjugatesFENG DANQING·Filed 2016·Application pending·0 cites
- 4342US2010234409A1Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activityYANG LIHU·Filed 2005·Application pending·0 cites
- 4441US2017248580A1Method for screening drug-saccharide conjugatesMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 4539US2008090865A1Antidiabetic Bicyclic CompoundsGE MIN·Filed 2006·Application pending·0 cites
- 4638US2019175744A1Insulin-incretin conjugatesPALANI ANANDAN·Filed 2017·Application pending·0 cites
- 4738US2017254798A1Method for screening drug-saccharide conjugatesMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 4837US2015320724A1Methods of treating diabetes by administering a glucagon receptor antagonist in combination with a cholesterol absorption inhibitorGUAN HONG-PING·Filed 2013·Application pending·0 cites
- 4936US10065945B2Isoquinoline derivatives as MGAT2 inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Sep 4, 2018·0 cites·14 claims
- 5033US8324384B2Glucagon receptor antagonist compounds, compositions containing such compounds and methods of useLIN SONGNIAN·Filed 2010·Granted Dec 4, 2012·0 cites·16 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Songnian Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →